Mouse models of myelin diseases

Brain Pathology

Volumn 8, Issue 4, 1998, Pages 771-793

  Werner, H ^a   Jung, M ^a   Klugmann, M ^a   Sereda, M ^a   Griffiths, I R ^b   Nave, K A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CONFERENCE PAPER; DEMYELINATING DISEASE; GENE MUTATION; GENETIC TRANSCRIPTION; MYELINATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; SCHWANN CELL;

EID: 0031659692     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00200.x     Document Type: Conference Paper

References (194)

1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U (1995) Hypermyelination and demyelinating peripheral neuropathy in PMP-22-deficient Mice. Nature Genet 11:274-280
2. Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U (1997) Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 17:4662-4671
3. Adlkofer K, Naef R, Suter U (1997) Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J Neurosci Res 49:671-680
4. Alroy I, Yarden Y (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410:83-86
5. Anderson TJ, Schneider A, Barne JA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave K-A, Griffiths IR (1998) Increased dosage of the proteolipid protein gene causes late-onset neurodegeneration. J. Comp. Neurol, 394: 506-519
6. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka KV, Suter U, Martini R (1997) Structural abnormalities and deficient maintenance of peripheral nerve myetin in mice lacking the gap junction protein connexin 32. J Neurosci 17:4545-4551
7. Aubourg P (1996) X-linked adrenoleukodystrophy. In Moser HW (ed): Handbook of Clinical Neurology Volume 22: Neurodystrophies and Neurolipidoses. Amsterdam: Elsevier, pp 447-483
8. Bartsch S, Montag D, Schachner M, Bartsch U (1997) Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG) Brain Res 762:231-234
9. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and ioss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14:717-730
10. Berger J, Molzer B, Fae I, Bernheimer H (1994) X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun 205:1638-1643
11. Bergoffen J, Scherer SS., Wang S, Oronzi SM, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039-2041
12. Bermingham JR Jr, Scherer SS, O'Connell S, Arroyo E, Kalla KA, Powell FL, Rosenfeld MG (1996) Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev 10:1751-1762
13. Boison D, Stoffel W (1994) Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci (USA) 91: 11709-11713
14. Boison D, Bussow H, D'Urso D, Muller HW, Stoffel W (1995) Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J Neurosci 5:5502-5513
15. Bone LJ, Deschenes SM, Balice-Gordon RJ, Fischbeck KH, Scherer SS (1997) Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 4:221-230.
16. Bosio A, Binczek E, Stoffel W (1996) Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci (USA) 93: 13280-13285
17. Bosio A, Bussow H, Adam J, Stoffel W (1998) Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res 292:199-210
18. Bruzzone R, White TW, Scherer SS, Fischbeck KH, Paul DL (1994) Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 13:1253-1260
19. Canoll PD, Petanceska S, Schlessinger J, Musacchio JM (1996) Three forms of RPTP-beta are differentially expressed during gliogenesis in the developing rat brain and during glial cell differentiation in culture. J Neurosci Res 44:199-215
20. Carenini S, Montag D, Cremer H, Schachner M, Martini R (1996) Absence of the myelin-associated glycoprotein (MAG) and the neural cell adhesion molecule (N-CAM) interferes with the maintenance, but not with the formation of peripheral myelin. Cell Tissue Res 287:3-9
21. Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M, Lai C (1997) Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387:512-516
22. Chang H, Riese DJ 2nd, Gilbert W, Stern DF, McMahan UJ (1997) Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 387:509-512
23. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R, Charnay P (1988) A gene encoding a protein with zinc fingers is activated during GO/G1 in cultured cells. EMBO J 7:29-35
24. Chen Y, Medvedev A, Ruzanov P, Marvin KW, Jetten AM (1997) cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics 41:40-48
25. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B (1996) Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability Cell 86, 209-219
26. Coetzee T, Suzuki K, Popko B (1998) New perspectives on the function of myelin galactolipids. Trends Neurosci 21:126-130
27. Colello RJ, Pott U (1997) Signals that initiate myelination in the developing mammalian nervous system. Mol Neurobiol 15:83-100
28. Cremers FP, Pfeiffer RA, van de Pol TJ, Hofker MH, Kruse TA, Wieringa B, Ropers HH (1987) An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum Genet 77:23-27
29. D'Urso D, Brophy PJ, Staugaitis SM, Gillespie CS, Frey AB, Stempak JG, Colman DR (1990) Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4:449-460
30. D'Urso D, Müller HW (1997) Ins and outs of peripheral myelin protein-22: mapping transmembrane topology and intracellular sorting. J Neurosci Res 49:551-562
31. D'Urso D, Schmalenbach C, Zoidl G, Pnor R, Muller HW (1997) Studies on the effects of altered PMP22 expression during myelination in vitro. J Neurosci Res 48:31-42
32. D'Urso D, Prior R, Greiner-Petter R, Gabreels-Festen AA, Muller HW (1998) Overloaded endoplasmic reticulumGolgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 18:731-740
33. de Cozar M, Lucas M, Monreal J (1987) lonophoric properties of the proteolipid apoprotein from bovine brain myelin. Biochem Int 14:833-841
34. Diaz RS, Monreal J, Lucas M (1990) Calcium movements mediated by proteolipid protein and nucleotides in liposomes prepared with the endogenous lipids from brain white matter. J Neurochem 55:1304-1309
35. Ding Y, Brunden KR (1994) The cytoplasmic domain of myelin glycoprotein PO interacts with negatively charged phospholipid bilayers. J Biol Chem 269:10764-10770
36. Doyle JP, Colman DR (1993) Glial-neuron interactions and the regulation of myelin formation. Curr Opin Cell Biol 5:779-785
37. Duncan ID, Hammang JP, Trapp BD (1987) Abnormal compact myelin in the myelin-deficient rat absence of proteolipid protein correlates with a defect in the intraperiod line. Proc Natl Acad Sci U S A 84:6287-6291
38. Duncan ID, Hammang JP, Goda S, Quarles RH (1989) Myelination in the jimpy mouse in the absence of proteclipid protein. Glia 2:148-154
39. Dupree JL, Coetzee T, Blight A, Suzuki K, Popko B (1998) Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J Neurosci 18: 1642-1649
40. Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (1993) Peripheral neuropathy Vol 2. WB. Saunders Company, Philadelphia
41. Einheber S, Zanazzi G, Ching W. Scherer S, Milner TA, Peles E, Salzer JL (1997) The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 139:1495-1506
42. Ellis D, Malcolm S (1994) Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease . Nature Genet 6:333-334
43. Fabbretti E, Edomi P, Brancolini C, Schneider C (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 9:1846-1856
44. Filbin MT, Walsh FS, Trapp BD, Pizzey JA, Tennekoon GI (1990) Role of myelin PO protein as a homophilic adhesion molecule. Nature 344:871-872
45. Filbin MT, Tennekoon GI (1993) Homophilic adhesion of the myelin PO protein requires glycosylation of both molecules in the homophilic pair. J Cell Biol 122:451-459
46. Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50:829-843
47. Fouquet F, Zhou JM, Ralston E, Murray K, Troalen F, Magal E, Robain O, Dubois-Dalcq M, Aubourg P (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 3:271-285
48. Frankel WN (1998) Mouse strain backgrounds' more than black and white. Neuron 20:183
49. Fruttiger M, Montag D, Schachner M, Martini R (1995) Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 7:511-515
50. Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ (1997) Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 inCharcot-Marie-Tooth disease type 1A and hereditaryneuropathy with liability to pressure palsies nerve biopsies. Neurology 49:1635-1640
51. Garbern JY, Cambi F, Tang XM, Sima AA, Vallat JM, Bosch EP, Lewis R, Shy M, Sohi J, Kraft G, Chen KL, Joshi I, Leonard DG, Johnson W, Raskind W, Dlouhy SR, Pratt V, Hodes ME, Bird T, Kamholz J (1997) Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19.205-218
52. Garcia CA, Malamut RE, England JD, Parry GS, Liu P, Lupski JR (1995) Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 45:2090-2093
53. Gassmann M, Lemke G (1997) Neuregulins and neuregulin receptors in neural development. Curr Opin Neurobiol 7:87-92
54. Gay CT, Hardies LJ, Rauch RA, Lancaster JL, Plaetke R, DuPont BR, Cody JD, Cornell JE, Herndon RC, Ghidoni PD, Schiff JM, Kaye CI, Leach RJ, Fox PT (1997) Magnetic resonance imaging demonstrates incomplete myelination in 18q-syndrome: evidence for myelin basic protein haploinsufficiency. Am J Med Genet 74:422-431
55. Gencic S, Hudson LD (1990) Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice. J Neurosci 10:117-124
56. Giese KP, Martini R, Lemke G, Soriano P, Schachner M (1992) Disruption of the PO gene in mice leads to abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576
57. Gow A, Friedrich VL, Lazzarini RA (1994) Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574-583
58. Gow A, Gragerov A, Gard A, Colman DR, Lazzarini RA (1997) Conservation of topology, but not conformation, of the proteolipid proteins of the myelin sheath. J Neurosci 17:181-189
59. Gow A, Lazzarini RA (1996) A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet 13:422-428
60. Gow A, Southwood CM, Lazzarini RA (1998) Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925-934
61. Gravel M, Peterson J, Yong VW, Kottis V, Trapp B, Braun PE (1996) Overexpression of 2′,3′-cyclic nucleotide 3′-phosphodiesterasein transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci 7:453-466
62. Griffiths IR, Scott I, McCulloch MC, Barrie JA, McPhilemy K, Cattanach BM (1990) Rumpshaker mouse: a new X-linked mutation affecting myelination: evidence for a defect in PLP expression. J Neurocytol 19.273-283
63. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280, 1610-1613.
64. Guenard V, Montag D, Schachner M, Martini R (1996) Onion bulb cells in mice deficient for myelin genes share molecular properties with immature, differentiated nonmyelinating, and denervated Schwann cells. Glia 18:27-38
65. Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van-Broeckhoven C, Mancardi GL, Bartke I, Müller HW (1994) Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 37:654-659
66. Harari D, Finkelstein D, Bernard O (1997) FGF plays a subtle role in oligodendrocyte maintenance in vivo. J Neurosci Res 49:404-415
67. Henry EW, Sidman RL (1988) Long lives for homozygous trembler mutant mice despite virtual absence of peripheral nerve myelin. Science 241 344-346
68. Hodes ME, Dlouhy SR (1996) The proteolipid protein gene: double, double. . . . and trouble. Am J Hum Genet 59: 12-15
69. Hoogendijk JE, Hensels GW, Gabreels-Festen AA, Gabreels FJ, Janssen EA, de Jonghe P, Martin JJ, van Broeckhoven C, Valentijn LJ, Baas F, et al. (1992) Denovo mutation in hereditary motor and sensory neuropathy type I. Lancet 339:1081-1082
70. Hortsch M (1996) The L1 family of neural cell adhesion molecules: old proteins performing new tricks. Neuron 17:587-593
71. Hudson LD, Ko N, Kim JG (1996) Control of myelin gene expression. In: Jessen KR, Richardson WD (eds): Glial cell development: basic principles and clinical relevance (Oxford: Bios Scientific Publishers) pp. 101-121
72. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563-569
73. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Fontes M (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449-458
74. Ionasescu W, Searby CC, Ionasescu R, Chatkupt S, Patel N, Koenigsberger R (1997) Dejenne-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 20:97-99
75. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D (1996) The POU factor Oct-6 and Schwann cell differentiation. Science 273:507-510
76. Johnson RS, Roder JC, Riordan JR (1995) Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem 64:967-976
77. Jung M, Schneider A, Nave KA (1995) Dominant-negative action of mutations in the PLP/DM-20 gene and direct interaction of PLP polypeptides in vivo. J Neurochem 64:S101.
78. Jung M, Sommer I, Schachner M, Nave KA (1996) Monoclonal antibody O10 defines a conformationally sensitive cell- surface epitope of proteolipid protein (PLP)' evidence that PLP misfolding underlies dysmyelination in mutant mice J Neurosci 16:7920-7929
79. Kadmon G, Altevogt P (1997) The cell adhesion molecule L1: species- and cell-type-dependent multiple binding mechanisms. Differentiation 61:143-150
80. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427-442
81. Kamholz J, Shy M, Scherer S (1994) Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 36:451-452
82. Kaplan MR, Meyer-Franke A, Lambert S, Bennett V, Duncan ID, Levinson SR, Barres BA (1997) Induction of sodium channel clustering by oligodendrocytes. Nature 386:724-728
83. Kioussi C, Gross MK, Gruss P (1995) Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15:553-562
84. Kirschner DA, Ganser, AL (1980) Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature 283:207-210
85. Kitagawa K, Sinoway MP, Yang C, Gould RM, Colman DR (1993) A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron 11:433-448
86. Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70
87. Kobayashi H, Hoffman EP, Marks HG (1994) The rumpshaker mutation in spastic paraplegia. Nat Genet 7:351-352
88. Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232:631-636
89. Koch T, Brugger T, Bach A, Gennarini G, Trotter J (1997) Expression of the immunoglobulin superfamily cell adhesion molecule F3 by oligodendrocyte-lineage cells. Glia 19: 199-212
90. Korenke GC, Fuchs S, Krasemann E, Doerr HG, Wilichowski E, Hunneman DH, Hanefeld F (1996) Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol 40:254-257
91. Korenke GC, Roth C, Krasemann E, Hufner M, Hunneman DH, Hanefeld F (1997) Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings. Eur J Endocrinol 137:40-47
92. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M (1998) Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18:237-250
93. Lassmann H, Bartsch U, Montag D, Schachner M (1997) Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency. Glia 19:104-110
94. Lees MB, Brostoff SW (1984) Proteins of myelin. In: Myelin (Ed. Morrell P) 197-224, Plenum Press, New York
95. Lemke G, Axel R (1985) isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40:501-508
96. Li C, Trapp B, Ludwin S, Peterson A, Roder J (1998) Myelin associated glycoprotein modulates glia-axon contact in vivo. J Neurosci Res 51:210-217
97. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerty W, Trapp B, Peterson A, Roder J (1994) Myelination in the absence of myelin-associated glycoprotein. Nature 369:747-750
98. Lipsitz D, Goetz BD, Duncan ID (1998) Apoptotic glial cell death and kinetics in the spinal cord of the myelin-deficient rat. J Neurosci Res 51:497-507
99. Livesey FJ, O'Brien JA, Li M, Smith AG, Murphy LJ, Hunt SP (1997) A Schwann cell mitogen accompanying regeneration of motor neurons. Nature 390:614-618
100. Lombard-Platet G, Savary S, Sarde CO, Mandel JL, Chimini G (1996) A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci U S A 93:1 265-1269
101. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci (USA) 94:9366-9371
102. Lupski JR (1998) Charcot-Marie-Tooth disease: lessons in genetic mechanisms. Mol Med 4: 3-11.
103. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka (1997) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360
104. Martini R, Schachner M (1986) Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve. J Cell Biol 103:2439-2448
105. Martini R, Mohajen MH, Kasper S, Giese KP, Schachner M (1995a) Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 15:4488-4495
106. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M (1995b) Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies Nature Genet 11:281-286
107. Martini R, Schachner M (1997) Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia 19:298-310
108. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA (1993) Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 36:315-324
109. Meyer D, Birchmeier C (1995) Multiple essential functions of neuregulin in development. Nature 378:386-390
110. Meyer D, Yamaai T, Garratt A, Riethmacher-Sonnenberg E, Kane D, Theill LE, Birchmeier C (1997) Isoform-specific expression and function of neuregulin. Development 124:3575-3586
111. Milner RJ, Lai C, Nave KA, Lenoir D, Ogata J, Sutcliffe JG (1985) Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 42:931-939
112. Molineaux SM, Engh H, de Ferra F, Hudson L, Lazzarini RA (1986) Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation. Proc Natl Acad Sci U S A 83:7542-7546
113. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, Karthigasan J, Kirschner DA, Wintergerst ES, Nave KA, et al (1994) Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13:229-246
114. Monuki ES, Kuhn R, Weinmaster G, Trapp BD, Lemke G (1990) Expression and activity of the POU transcription factor SCIP. Science 249:1300-1303
115. Moser HW, Powers JM, Smith KD (1995) Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil. Brain Pathol 5:259-266
116. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726-730
117. Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, Lopez J, Aubourg P, Mandel JL (1994) The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 3:265-271
118. Nadon NL, Arnheiter H, Hudson LD (1994) A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J Neurochem 63:822-833
119. Naef R, Adlkofer K, Lescher B, Suter U (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 9:13-25
120. Nave KA, Boespflug-Tanguy O (1996) X-linked developmental defects of myelination: from mouse mutants to human genetic diseases. Neuroscientist 2:33-43
121. Nave KA, Bloom FE, Milner RJ (1987) A single nucleotide difference in the gene for myelin proteolipid protein defines the jimpy mutation in mouse. Neurochem 49:1873-1877
122. Nave KA, Lai C, Bloom FE, Milner RJ (1986) Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci U S A 83:9264-9268
123. Noebels JL, Marcom PK, Jalilian-Tehrani MH (1991) Sodium channel density in hypomyelinated brain increased by myelin basic protein gene deletion. Nature 352:431-434
124. Notterpek L, Shooter EM, Snipes GJ (1997) Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J Neurosci 17: 4190-4200
125. Patel PI, Lupski JR (1994) Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet 10:128-133
126. Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y (1993) Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J 12:961-971
127. Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Bamea G, Plowman GD, et al (1995) The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 82:251-260
128. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccherini I, Romeo G, Smith JC, Read AP, Wegner M, Goossens M (1998) SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18:171-173
129. Popko B, Puckett C, Lai E, Shine HD, Readhead C, Takahashi N, Hunt SW, Sidman RL, Hood L (1987) Myelin deficient mice, expression of myelin basic protein and generation of mice with varying levels of myelin. Cell 48:713-721.
130. Popot JL, Pham Dinh D, Dautigny A (1991) Major myelin proteolipid: the 4-alpha-helix topology J Membr Biol 120:233-246
131. Powers JM, Moser HW (1998) Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis Brain Pathol 8:101-120
132. Privat A, Jaque C, Bourre JM, Dupouye P, Baumann N (1979) Absence of the major dense line in myelin of the mutant mouse 'shiverer'. Neurosci Lett 12:107-112
133. Ranscht B (1988) Sequence of contactin, a 130-kD glycoprotein concentrated in areas of interneuronal contact, defines a new member of the immunoglobulin supergene family in the nervous system. J Cell Biol 107:1561-1573
134. Raskind WH, Williams CA, Hudson LD, Bird TD (1991) Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Hum Genet 49:1355-1360
135. Readhead C, Popko B, Takahashi N, Shine HD, Saavedra RA, Sidman RL, Hood L (1987) Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 48:703-712
136. Readhead C, Schneider A, Griffiths I, Nave KA (1994) Premature arrest of myelin formation in transgenic mice with increased dosage of the proteolipid protein gene. Neuron 12:583-595
137. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR (1996) A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nature Genet 12:288-297
138. Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, Yamaai T, Lewin GR, Birchmeier C (1997) Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389:725-730
139. Roach A, Boylan K, Horvath S, Prusiner SB, Hood LE (1983) Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34:799-806
140. Roach A, Takahashi N, Pravtcheva D, Ruddle F, Hood L (1985) Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice. Cell 42:149-155
141. Rosenbluth J (1980) Central myelin in the mouse mutant shiverer. J Comp Neurol 194: 639-648
142. Roussel G, Neskovic NM, Trifilieff E, Artault JC, Nussbaum JL (1987) Arrest of proteolipid transport through the Golgi apparatus in Jimpy brain. J Neurocytol 16:195-204
143. Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, Gil R, Boespflug-Tanguy O (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257-262
144. Scherer SS, Bone U, Geschenes SM, Fischbeck K, Balice-Gordon RJ (1997) The role of gap junction protein connexin32 in the myelin sheath. in: Cell biology and pathology of myelin: evolving biological concepts and therapeutic approaches (Eds. R.M. Devon, R. Doucette, B.H.J. Juurlink, A.J. Nazarali, D.J. Schreyer, and V.M.K. Verge). Plenum Press, New York, pp. 83-102.
145. Schliess F, Stoffel W (1991) Evolution of the myelin integral membrane proteins of the central nervous system. Biol Chem Hoppe Seyler 372:865-874
146. Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, Brophy P, Nave KA (1992) Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358:758-761
147. Schneider AM, Griffiths IR, Readhead C, Nave KA (1995) Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci USA 92:4447-4451
148. Schneider C, King RM, Philipson L (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787-793
149. Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, Babinet C, Charnay P (1993) Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 75:1199-1214
150. Seitelberger F (1995) Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol 5: 267-273
151. Sereda M, Griffiths I, Puhlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049-1060
152. Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrikson WA (1996) Crystal structure of the extracellular domain from P0, the major structural protein of the peripheral nerve myelin. Neuron 17:435-449
153. Shine HD, Readhead C, Popko B, Hood L, Sidman RL (1992) Morphometric analysis of normal, mutant, and transgenic CNS: correlation of myelin basic protein expression to myelinogenesis. J Neurochem. 58:342-349
154. Sidman RL, Dickie MM, Apple SH (1964) Mutant mice (quaking and jimpy) with deficient myelination in the central nervous system. Science 144:309-311
155. Sinoway MP, Kitagawa K, Timsit S, Hashim GA, Colman DR (1994) Proteolipid protein interactions in transfectants: implications for myelin assembly. J Neurosci Res 37:551-562
156. Sistermans EA, de Wijs IJ, de Coo RF, Smit LM, Menko FH, van Oost BA (1996) A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family Hum Genet 97:337-339
157. Skoff RP (1982) Increased proliferation of oligodendrocytes in the hypomyelinated mouse mutant-jimpy. Brain Res 248:19-31
158. Snipes GJ, Suter U, Welcher AA, Shooter EM (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 117:225-238
159. Southard-Smith EM, Kos L, Pavan WJ (1998) Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 18:60-64
160. Sprinkle TJ (1989) 2′,3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4:235-301
161. Stoffel W, Bosio A (1997) Myelin glycolipids and their functions. Curr Opin Neurobiol 7: 654-661
162. Suter U, Welcher AA, Ozcelik T, Snipes GJ, Kosaras B, Francke U, Billings-Gagliardi S, Sidman RL, Shooter EM (1992a) Trembler mouse carries a point mutation in a myelin gene. Nature 356:241-244
163. Suter U, Moskow JJ, Welcher AA, Snipes GJ, Kosaras B, Sidman RL, Buchberg AM, Shooter EM (1992b) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci U S A 89:4382-4386
164. Suter U, Snipes GJ (1995a) Peripheral myelin protein 22: facts and hypotheses. J Neurosci Res 40:145-151
165. Suter U, Snipes GJ (1995b) Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 18:45-75
166. Swiatek PJ, Gridley T (1993) Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 11:2071-2084
167. Tassabehji M, Newton VE, Liu XZ, Brady A, Donnai D, Krajewska-Walasek M, Murday V, Norman A, Obersztyn E, Reardon W, et al (1995) The mutational spectrum in Waardenburg syndrome. Hum Mol Genet 11:2131-2137
168. Taylor V, Suter U (1996) Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene 175:115-120
169. Thomson CE, Montague P, Jung M, Nave KA, Griffiths IR (1997) Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia 20:322-332
170. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799
171. Vabnick I, Messing A, Chiu SY, Levinson SR, Schachner M, Roder J, Li C, Novakovic S, Shrager P (1997) Sodium channel distribution in axons of hypomyelinated and MAG null mutant mice. J Neurosci Res 50:321-336
172. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NH, Zorn I, Gabreels-Festen AW, de Visser M, Bolhuis PA (1992) identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 2:288-291
173. Vallat JM, Sindou P, Preux PM, Tabaraud F, Milor AM, Couratier P, LeGuern
174. Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D, Bodell A, Nelis E, Van Broeckhoven C, Lupski JR (1996) Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination Neuron :451-460
175. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, Lupski JR (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 4:382-384
176. Warner LE, Reiter LT, Murakami T, Lupski JR (1996) Molecular mechanisms for Charcot-Marte-Tooth disease and related demyelinating peripheral neuropathies. Cold Spring Harb Symp Quant Biol 61:659-671
177. Waxman SG (1997) Axon-glia interactions: building a smart nerve fiber. Curr Biol 7:R406-R410
178. Weimbs T, Stoffel W (1992) Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31:12289-12296
179. Weinstein DE, Burrola PG, Lemke G (1995) Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. Mol Cell Neurosci 6:212-229.
180. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, Lupski JR (1993) Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am. J. Hum. Genet 53:853-63
181. Wong MH, Filbin MT (1994) The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain. J Cell Biol 126:1089-1097
182. Wong MH, Filbin MT (1996) Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain. J Cell Biol 134:1531-1541
183. Wrabetz L, Feltri M, Quattrini A, Arona M, Trapp B, Messing A (1996) Increased P0 glycoprotein gene dosage causes a dysmyelinating peripheral neuropathy in transgenic mice. Soc Neurosci Abstr 22: 1980
184. Xu Z, Dong DL, Cleveland DW (1994) Neuronal intermediate filaments: new progress on an old subject. Curr Opin Neurobiol 4:655-661
185. Yamamoto Y, Mizuno R, Nishimura T, Ogawa Y, Yoshikawa H, Fujimura H, Adachi E, Kishimoto T, Yanagihara T, Sakoda S (1994) Cloning and expression of myelin-associated oligodendrocytic basic protein. A novel basic protein constituting the central nervous system myelin. J Biol Chem 269:31725-31730
186. Ye P, Carson J, D'Ercole AJ (1995) In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15:7344-7356
187. Yin X, Crawford TO, Griffin JW, Tu Ph, Lee VM, Li C, Roder J, Trapp BD (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962
188. Yin X, Peterson J, Gravel M, Braun PE, Trapp BD (1997) CNP Overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J. Neurosc. Res.50:238-47
189. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, Sakoda S, Yanagihara T (1994) Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann. Neurol. 35:445-450
190. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, Hillan K, Crowley C, Brush J, Godowski PJ (1997) Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A 94:9562-9567
191. Zhang K, Filbin MT (1994) Formation of a disulfide bond in the immunoglobulin domain of the myelin P0 protein is essential for its adhesion. J Neurochem 63:367-370
192. Zhang K, Merazga Y, Filbin MT (1996) Mapping the adhesive domains of the myelin Po protein. J Neurosci Res 45:525-533
193. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 14:1122-1128
194. Zonck TS, Syroid DE, Arroyo E, Scherer SS, Lemke G (1996) The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8:129-145